表紙
市場調查報告書

手術用網膜:開發平台分析

Surgical Mesh - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 344638
出版日期 內容資訊 英文 90 Pages
訂單完成後即時交付
價格
手術用網膜:開發平台分析 Surgical Mesh - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年10月31日內容資訊: 英文 90 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的外科手術用網膜之開發中產品資訊相關分析,提供您臨床實驗/產品開發的整體進展,及各階段·各領域·各地區的詳細趨勢,各企業·各產品的詳細資訊 (臨床實驗的進展階段,開始/結束時期,認證預測等),近來的產品開發的動向·產業趨勢等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各認證時期 (估計)
  • 現在進行中的臨床實驗

第4章 手術用網膜:現在正在開發的開發中產品 (各企業)

  • 手術用網膜的開發企業:開發中產品 (各開發階段)
  • 手術用網膜:各開發階段的開發中產品一覽

第5章 手術用網膜的企業·產品概要

  • Acera Surgical, Inc.
    • 開發中產品及現在進行中的臨床實驗概要
  • Admedus Ltd
  • Allergan, Inc.
  • Anika Therapeutics, Inc.
  • ARISTE Medical
  • Atrium Medical Corporation
  • BioLineRx, Ltd.
  • Boston Scientific Corporation
  • Cytograft Tissue Engineering, Inc.
  • DSM Biomedical B.V.
  • Ethicon, Inc.
  • Generic Medical Devices, Inc.
  • Harbor MedTech, Inc.
  • Hernia Solutions Ltd.
  • Kerecis ehf
  • Kinetic Concepts, Inc.
  • LifeBond Ltd.
  • Medisse BV
  • Medlinx Acacia Pte Ltd
  • Medtronic plc
  • MicroPort Scientific Corporation
  • MiMedx Group, Inc
  • Montana State University
  • Nanovis Incorporated
  • PolyNovo Biomaterials Pty Ltd
  • Proxy Biomedical Limited
  • Retectix, LLC
  • Revivicor, Inc.
  • Samyang Biopharmaceuticals Corporation
  • Semprus BioSciences
  • Soft Tissue Regeneration, Inc.
  • Tepha, Inc.
  • The Electrospinning Company Ltd
  • The Johns Hopkins University
  • University of Maryland, Baltimore
  • University of South Florida
  • Via Surgical Ltd.
  • Xylos Corporation

第6章 手術用網膜:近來的市場趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1021EPD

GlobalData's Medical Devices sector report, "Surgical Mesh - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Surgical Meshs pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Surgical Mesh is an implantable device that reinforces the growth of soft tissues. It is also used to support the structures of the body from getting prolapsed.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Surgical Mesh under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Surgical Mesh and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Surgical Mesh under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of

  • 1.1 List of
  • 1.2 List of

2

  • 2.1 Surgical Mesh

3 Products under

  • 3.1 Surgical Mesh - Pipeline Products by Stage of
  • 3.2 Surgical Mesh - Pipeline Products by
  • 3.3 Surgical Mesh - Pipeline Products by Regulatory
  • 3.4 Surgical Mesh - Pipeline Products by Estimated Approval
  • 3.5 Surgical Mesh - Ongoing Clinical

4 Surgical Mesh - Pipeline Products under Development by

  • 4.1 Surgical Mesh Companies - Pipeline Products by Stage of
  • 4.2 Surgical Mesh - Pipeline Products by Stage of

5 Surgical Mesh Companies and Product

  • 5.1 Acera Surgical, Inc. Company
    • 5.1.1 Acera Surgical, Inc. Pipeline Products & Ongoing Clinical Trials
  • 5.2 Anika Therapeutics Inc Company
    • 5.2.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials
  • 5.3 Anteris Technologies Ltd Company
    • 5.3.1 Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials
  • 5.4 Aran Biomedical Company
    • 5.4.1 Aran Biomedical Pipeline Products & Ongoing Clinical Trials
  • 5.5 Biorez Inc Company
    • 5.5.1 Biorez Inc Pipeline Products & Ongoing Clinical Trials
  • 5.6 Boston Scientific Corp Company
    • 5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials
  • 5.7 CorMedix Inc Company
    • 5.7.1 CorMedix Inc Pipeline Products & Ongoing Clinical Trials
  • 5.8 DSM Biomedical BV Company
    • 5.8.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials
  • 5.9 Fibralign Corporation Company
    • 5.9.1 Fibralign Corporation Pipeline Products & Ongoing Clinical Trials
  • 5.10 Johns Hopkins University Company
    • 5.10.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials
  • 5.11 Medisse BV (Inactive) Company
    • 5.11.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials
  • 5.12 Polyganics BV Company
    • 5.12.1 Polyganics BV Pipeline Products & Ongoing Clinical Trials
  • 5.13 Refine LLC Company
    • 5.13.1 Refine LLC Pipeline Products & Ongoing Clinical Trials
  • 5.14 Retectix, LLC Company
    • 5.14.1 Retectix, LLC Pipeline Products & Ongoing Clinical Trials
  • 5.15 Samyang Biopharmaceuticals Corp Company
    • 5.15.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials
  • 5.16 Silver Bullet Therapeutics, Inc. Company
    • 5.16.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials
  • 5.17 Surgical Innovation Associates Inc Company
    • 5.17.1 Surgical Innovation Associates Inc Pipeline Products & Ongoing Clinical Trials
  • 5.18 T&R Biofab Co Ltd Company
    • 5.18.1 T&R Biofab Co Ltd Pipeline Products & Ongoing Clinical Trials
  • 5.19 TEI Biosciences Inc Company
    • 5.19.1 TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials
  • 5.20 Tela Bio Inc Company
    • 5.20.1 Tela Bio Inc Pipeline Products & Ongoing Clinical Trials
  • 5.21 Tepha Inc Company
    • 5.21.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials
  • 5.22 The Electrospinning Company Ltd Company
    • 5.22.1 The Electrospinning Company Ltd Pipeline Products & Ongoing Clinical Trials
  • 5.23 University of Maryland Baltimore Company
    • 5.23.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials
  • 5.24 University of Sheffield Company
    • 5.24.1 University of Sheffield Pipeline Products & Ongoing Clinical Trials
  • 5.25 University of South Florida Company
    • 5.25.1 University of South Florida Pipeline Products & Ongoing Clinical Trials

6 Surgical Mesh- Recent

  • 6.1 Oct 20, 2020: Information for medical practitioners on pending up-classification of surgical mesh
  • 6.2 Sep 25, 2020: Company to pay $60M for deceptive marketing with pelvic
  • 6.3 Jul 13, 2020: DSM appoints Cristina Monteiro new EVP People & Organization and member of the Executive
  • 6.4 Jul 01, 2020: DSM appoints Zhou Tao (Joe) as President DSM
  • 6.5 May 07, 2020: DSM to help accelerate Dutch Covid-19 testing by making 2.8 million nose
  • 6.6 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston
  • 6.7 Apr 08, 2020: Wright Medical Group announces virtual meeting alternative to physical attendance at Extraordinary General Meeting of Shareholders and change of time and location of
  • 6.8 Apr 08, 2020: Anika takes actions to strengthen liquidity in light of
  • 6.9 Apr 06, 2020: MiMedx Group agrees to pay $6.5 million to resolve false claims act allegations of false commercial pricing
  • 6.10 Mar 03, 2020: CEO Richard Twomey leaves
  • 6.11 Feb 26, 2020: Endo reports fourth-quarter and full-year 2019 financial
  • 6.12 Feb 25, 2020: DSM appoints new EVP Materials and member of the Executive
  • 6.13 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity
  • 6.14 Feb 24, 2020: AbbVie announces extension of expiration date for exchange offers for Allergan
  • 6.15 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity
  • 6.16 Feb 21, 2020: Coloplast - Announcement no. 2/2020 - share buyback
  • 6.17 Feb 19, 2020: Endo names Blaise Coleman president and chief executive
  • 6.18 Feb 19, 2020: Endo appoints Mark G. Barberio to board of
  • 6.19 Feb 18, 2020: Medtronic reports third quarter financial results
  • 6.20 Feb 13, 2020: CryoLife reports fourth quarter and full year 2019 financial
  • 6.21 Feb 13, 2020: DSM reports 2019
  • 6.22 Feb 06, 2020: Coloplast: Interim financial report, Q1
  • 6.23 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year
  • 6.24 Jan 20, 2020: DSM names Feike Sijbesma Honorary
  • 6.25 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year
  • 6.26 Dec 20, 2019: Cook Medical applauds congressional action to repeal the medical device excise
  • 6.27 Dec 16, 2019: MiMedx Announces addition of Peter M.
  • 6.28 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in
  • 6.29 Dec 03, 2019: Collagen Solutions: Interim Results for the six months ended 30 September
  • 6.30 Dec 03, 2019: RTI Surgical accelerates business transformation with senior leadership
  • 6.31 Nov 26, 2019: MiMedx announces Securities and Exchange Commission
  • 6.32 Nov 26, 2019: TGA response to federal court decision on urogynaecological mesh class
  • 6.33 Nov 26, 2019: MiMedx names William "Butch" Hulse as General Counsel and
  • 6.34 Nov 26, 2019: SEC charges biotech company and executives with accounting
  • 6.35 Nov 19, 2019: Medtronic reports second quarter financial results for the year
  • 6.36 Nov 13, 2019: Collagen Solutions: Directorate
  • 6.37 Nov 12, 2019: Cook Medical's leadership updates in Asia-pacific reinforce focus on growth and physician
  • 6.38 Nov 11, 2019: BioLineRx reports third quarter 2019 financial results and provides corporate
  • 6.39 Nov 05, 2019: Surgical Innovation Associates recent series A supercharged with $2M grant from US National Cancer Institute
  • 6.40 Nov 05, 2019: Stryker signs agreement to acquire Wright Medical for
  • 6.41 Nov 05, 2019: Coloplast delivers a strong full-year result and the company concludes that the interventional urology business remains core to its future value
  • 6.42 Nov 05, 2019: Coloplast announced its full-year financial results

7

  • 7.1
  • 7.2 About
  • 7.3 Contact
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Surgical Mesh - Pipeline Products by Stage of
  • Table 2: Surgical Mesh - Pipeline Products by
  • Table 3: Surgical Mesh - Pipeline Products by Regulatory
  • Table 4: Surgical Mesh - Pipeline Products by Estimated Approval
  • Table 5: Surgical

List of Figures

List of Figures

  • Figure 1: Surgical Mesh - Pipeline Products by Stage of
  • Figure 2: Surgical Mesh - Pipeline Products by
  • Figure 3: Surgical Mesh - Pipeline Products by Regulatory
  • Figure 4: Surgical Mesh - Pipeline Products by Estimated Approval
  • Figure 5: Surgical Mesh - Ongoing Clinical